Glyoxal compositum contains methyl glyoxal and oxalaldehyde which, according to Professor W. Frederik Koch, have a far-reaching action on the widest variety of degenerative diseases.
According to Professor Koch, methyl glyoxal and oxalaldehyde, as members of what is known as the carbonyl group series, have the property of deblocking blocked energy-producing systems of the cells, as well, by way of depolymerization of homotoxins and carcinotoxins, as dissolving a cancerous formation already in progress, by means of the action of the free radicals, which is possible both through quinones and through free carbonyl groups. In this way, through the free carbonyl groups and quinones, by means of hydrogen removal, the impregnation phase, to some extent, is broken up therapeutically. (see also the work by Reckeweg: New viewpoints on antihomotoxic therapy in cellular phases, Homotoxin Joumal 6. 285 305 (1967)). It has proved beneficial, in treatment with Glyoxal compositum, to interpose preparations such as Coenzyme compositum ampoules, Ubichinon compositum ampoules, Thyreoidea compositum etc., or to administer them in succession.
Also Hepar compositum (stimulation of the detoxicating hepatic function) can be interposed advantageously, while in cases of powerful regressive vicariation and the appearance of inflammatory symptoms, Traumeel S and Echinacea compositum S are indicated. Cancer therapy is based, among other preparations, on Viscum compositum (mite, medium, forte), Coenzyme compositum ampoules, Ubichinon compositum ampoules, Galium-Heel, Psorinoheel and Lymphomyosot (the latter also orally), in alternating injections every 1-2 days. Glyoxal compositum, in general, should be interposed only when improvement flags. See also Neoplasia and Neoplamaphases. As alternating remedies, Para-Benzochinon-Injeel and cAMP D 30 are to be considered primarily.
The dosage is adjusted according to the disease, the clinical picture and the stage of the illness.
|created with Help to RTF file format converter|